DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/q7vn64/investigation) has announced the addition of the "Investigation Report on China's Cilostazol Market, 2010-2019" report to their offering.
Cilostazol is a medication used in the alleviation of chronic ulcer, pain, chills and intermittent claudication caused by limb ischemia. It is also frequently used to alleviate symptoms, improve circulation and inhibit thrombus in the postoperative treatment of angioplasty, vascular graft and sympathectomy. As a nation with the largest population in the world, China reports a huge demand for medicines. Currently, as population structure changes and environmental problems spring up, the Chinese people's health suffers from great harm. Cilostazol with its medicinal properties will enjoy a large market and play an important role in future.
Cilostazol develops fast after entering China, with annual sales rising from CNY 35.95 million in 2010 to CNY 66.91 million in 2014 and CAGR during this period reached 16.80%. Cilostazol enjoys a vast demand in China. Otsuka Co., Ltd, Zhejiang Weikang Pharmaceutical Co., Ltd, Chengdu Leer Pharmaceutical Co., Ltd, Pharsin and Yantai Yisheng Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among of which Otsuka Co., Ltd had the largest market share of about 63.62% with sales value reaching up to CNY 42.57 million in 2014.
Key Topics Covered:
1 Related Concepts of Cilostazol
2 Market Profile of Cilostazol in China
3 Survey on Cilostazol Sales in China, 2010-2014
4 Survey on Market Share of Major Cilostazol Manufacturers in China, 2010-2014
5 Survey on Dosage Forms of Cilostazol in China, 2010-2014
6 Reference Price of Cilostazol in Chinese Hospitals in 2014
7 Major Manufacturers of Cilostazol in Chinese Market, 2010-2014
8 Market Outlook of Cilostazol in China, 2015-2019
- Chengdu Leer Pharmaceutical Co., Ltd
- Chongqing Pharscin pharmaceutical Co. Ltd.
- Yantai Yisheng Pharmaceutical Co., Ltd
- Zhejiang Otsuka Pharmaceutical Co.,Ltd.
- Zhejiang Weikang Pharmaceutical Co., Ltd
For more information visit http://www.researchandmarkets.com/research/q7vn64/investigation